Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.51 |
| ▸ | MAPT | P10636 | 5/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.45 |
| ▸ | GAA | P10253 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7467600 | 0.85 | L3MBTL1 (0.46) | L3MBTL1MAPTCYP1A2CYP3A4TSHR | |
| SCHEMBL18184934 | 0.83 | CA12 (0.47) | L3MBTL1MAPTCYP1A2CYP3A4TSHR | |
| SCHEMBL18184933 | 0.81 | L3MBTL1 (0.42) | L3MBTL1MAPTCYP1A2CYP3A4TSHR | |
| SCHEMBL1047553 | 0.81 | MAPT (0.70) | L3MBTL1MAPTCYP1A2CYP3A4TSHR | |
| SCHEMBL14322127 | 0.81 | SLC6A2 (0.32) | KMT2AATM | |
| SCHEMBL27736617 | 0.80 | CNR1 (0.50) | L3MBTL1MAPTCYP1A2CYP3A4TSHR | |
| SCHEMBL27736616 | 0.80 | CNR1 (0.50) | L3MBTL1MAPTCYP1A2CYP3A4TSHR | |
| SCHEMBL3695529 | 0.77 | ALDH1A1 (0.62) | L3MBTL1MAPTCYP1A2CYP3A4TSHR | |
| SCHEMBL270836 | 0.73 | SLC6A2 (0.44) | TSHRKMT2AATM | |
| SCHEMBL14528752 | 0.72 | AURKA (0.34) | MAPTCYP3A4TDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118878853-A | Synthesis method and application of porphyrin metal organic framework-based nanomaterial catalyst | 安阳工学院 | 2024-11-01 | — | — | CN | disclosed |
| EP-2938619-B1 | MEGASTOKES AMINO-TRIAZOLYL-BODIPY COMPOUNDS AND APPLICATIONS TO LIVE NEURON STAINING AND HUMAN SERUM ALBUMIN FA1 DRUG SITE PROBING | NAT UNIV SINGAPORE (SG) | 2018-02-21 | — | — | EP | disclosed |
| US-9513294-B2 | Megastokes amino-triazolyl-BODIPY compounds and applications to live neuron staining and human serum albumin FA1 drug site probing | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2016-12-06 | — | — | US | disclosed |
| US-9513294-B2 | Megastokes amino-triazolyl-BODIPY compounds and applications to live neuron staining and human serum albumin FA1 drug site probing | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2016-12-06 | — | — | US | disclosed |
| US-9513294-B2 | Megastokes amino-triazolyl-BODIPY compounds and applications to live neuron staining and human serum albumin FA1 drug site probing | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2016-12-06 | — | — | US | disclosed |
| EP-2938619-A1 | MEGASTOKES AMINO-TRIAZOLYL-BODIPY COMPOUNDS AND APPLICATIONS TO LIVE NEURON STAINING AND HUMAN SERUM ALBUMIN FA1 DRUG SITE PROBING | National University of Singapore (SG) | 2015-11-04 | — | — | EP | disclosed |
| US-20150309040-A1 | Megastokes Amino-Triazolyl-Bodipy Compounds And Applications To Live Neuron Staining And Human Serum Albumin FA1 Drug Site Probing | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-10-29 | — | — | US | disclosed |
| US-20150309040-A1 | Megastokes Amino-Triazolyl-Bodipy Compounds And Applications To Live Neuron Staining And Human Serum Albumin FA1 Drug Site Probing | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-10-29 | — | — | US | disclosed |
| US-20150309040-A1 | Megastokes Amino-Triazolyl-Bodipy Compounds And Applications To Live Neuron Staining And Human Serum Albumin FA1 Drug Site Probing | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-10-29 | — | — | US | disclosed |
| WO-2014104975-A1 | MEGASTOKES AMINO-TRIAZOLYL-BODIPY COMPOUNDS AND APPLICATIONS TO LIVE NEURON STAINING AND HUMAN SERUM ALBUMIN FA1 DRUG SITE PROBING | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2014-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150309040-A1 | Megastokes Amino-Triazolyl-Bodipy Compounds And Applications To Live Neuron Staining And Human Serum Albumin FA1 Drug Site Probing | FABP7, FABP1, FABP3 | L3MBTL1 932/4885MAPT 540/4885CYP1A2 3107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.